Adenovirus infection induces microglial activation: Involvement of mitogen-activated protein kinase pathways

Brain Research

Volumn 948, Issue 1-2, 2002, Pages 93-101

  Bhat, Narayan R ^a   Fan, Fan ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adenovirus; Gene therapy; Inducible nitric oxide synthase; Mitogen activated protein kinase; Neuroinflammation; TNF

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BRAIN; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE THERAPY; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MEDIATOR RELEASE; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TISSUE CULTURE; VIRUS INFECTION;

ADENOVIRIDAE INFECTIONS; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME ACTIVATORS; ENZYME INHIBITORS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MACROMOLECULAR SUBSTANCES; MAP KINASE SIGNALING SYSTEM; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037032091     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02953-0     Document Type: Article

References (36)

1. Adesanya M.R., Redman R.S., Baum B.J., O'Connell B.C. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 7:1996;1085-1093.
2. Alcorn M.J., Booth J.L., Coggeshall K.M., Metcalf J.P. Adenovirus type 7 induces interleukin-8 production via activation of extracellular signal regulated kinase 1/2. J. Virol. 75:2001;6450-6459.
3. Barkats M., Bilangbleuel A., Buccaron M.H., Castelbarthe M.N., Corti O., Finiels F., Horellou P., Revah F., Sabate O., Mallet J. Adenovirus in the brain - recent advances of gene therapy for neurodegenerative diseases. Prog. Neurobiol. 55:1998;333-341.
4. Bhat N.R., Zhang P., Lee J.C., Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factorα gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18:1998;1633-1641.
5. Bhat N.R., Zhang P., Bhat A.N. Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: role of p38 MAP kinase activation. J. Neurochem. 72:1999;472-484.
6. Bruder J.T., Kovesdi I. Adenovirus infection stimulates the Raf/MAPK signalling pathway and induces interleukin-8 expression. J. Virol. 71:1997;398-404.
7. Byrnes A.P., Rusby J.E., Wood M.J.A., Charlton H.M. Adenovirus gene transfer causes inflammation in the brain. Neuroscience. 66:1995;1015-1024.
8. Cartmell T., Southgate T., Rees G.S., Castro M.G., Lowenstein P.R., Luheshi G.N. Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. J. Neurosci. 19:1999;1517-1523.
9. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
10. Cobb M. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71:1999;479-500.
11. Costantini L.C., Bakowska J.C., Breakefield X.O., Isacson O. Gene therapy in the CNS. Gene Ther. 7:2000;93-109.
12. Devergne O., Peuchmaur M., Humbert M., Navratil E., Leger-Ravet M.B., Crevon M.C., Petit M.A., Galanaud P., Emilie D. In vivo expression of IL-1 beta and IL-6 genes during viral infection in human. Eur. Cytokine Netw. 2:1991;183-194.
13. Dewey R.A., Morrissey G., Cowsill C.M., Stone D., Bolognani F., Dodd N.J.F., Southgate T.D., Klatzmann D., Lassmann H., Castro M.G., Lowenstein P.R. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials. Nat. Med. 5:1999;1256-1263.
14. During M.J., Ashenden L.M.A. Towards gene therapy for the central nervous system. Mol. Med. Today. 4:1998;485-493.
15. Elkon K.B., Liu C.C., Gall J.G., Trevejo J., Marino M.W., Abrahamsen K.A., Song X., Zhou J.L., Old L.J., Crystal R.G., Falck-Pedersen E. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc. Natl. Acad. Sci. USA. 94:1997;9814-9819.
16. Fathallah-Shaykh H.M., Kafrouni A.I., Zhao L.-J., Diaz-Arrastia R., Garcia J.A., Frawley W.H., Forman J. Demyelination but no cognitive motor or behavioural deficits after adenovirus-mediated gene transfer into the brain. Gene Ther. 7:2000;2094-2098.
17. Friedmann T. Gene therapy for neurological disorders. Trends Genet. 10:1994;210-214.
18. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated signalling pathways. Curr. Opin. Cell Biol. 11:1999;211-218.
19. Ginsberg H.S., Prince G.A. The molecular basis of adenovirus pathogenesis. Infect. Agents Dis. 3:1994;1-8.
20. Ginsberg H.S., Moldaver L.L., Sehgal P.B., Redington M., Kilian P.L., Chanock R.M., Prince G.A. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA. 88:1991;1651-1655.
21. Kielian T., Hickey W.F. Inflammatory thoughts about glioma gene therapy. Nat. Med. 5:1999;1237-1238.
22. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:2001;807-869.
23. Li E., Stupack D., Brown S.L., Klemke R., Schlaepfer D.D., Nemerow G.R. Association of p130CAS with phosphoinositide-3-OH kinase mediates adenovirus cell entry. J. Biol. Chem. 275:2000;14729-14735.
24. Lieber A., He C.Y., Meuse L., Schowalter D., Kirillowva I., Winther B., Kay M.A. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 71:1997;8798-8807.
25. Makarov S.S. NF-B as a therapeutic target in inflammation: recent advances. Mol. Med. Today. 6:2000;441-448.
26. Marshall E. Gene therapy on trial. Science. 288:2000;951-957.
27. McCoy R.D., Davidson B.L., Roessler B.J., Huffnagle G.B., Janich S.L., Laing T.J., Simon R.H. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6:1995;1553-1560.
28. Stevenson P.G., Hawke S., Sloan D.J., Bangham C.R. The immunogenicity of intracerebral virus infection depends on anatomical site. J. Virol. 71:1997;145-151.
29. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:1995;437-457.
30. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalisation but not virus attachment. Cell. 73:1993;309-319.
31. Wood M.J., Charlton H.M., Wood K.J., Kajiwara K., Byrnes A.P. Immune responses to adenoviral vectors in the nervous system. Trends Neurosci. 19:1996;497-501.
32. Worgall S., Wolff G., Flack-Pedersen E., Crystal R.G. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8:1997;37-44.
33. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
34. Yang Y., Li Q., Ertl H.C., Wilson J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
35. Yang Y., Su Q., Wilson J.M. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:1996;7209-7212.
36. Zsengeller Z., Otake K., Hossain S.-A., Berclaz P.-Y., Trapnell B.C. Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signalling during acute respiratory tract infection. J. Virol. 74:2000;9655-9667.